Back to News
Market Impact: 0.15
Bioxytran Secures Attested Free Sale Certification for A-SUQAR®, Opening the Path to the UAE and Gulf Markets
Source: globenewswire.com
Healthcare & BiotechProduct LaunchesEmerging Markets
A non-systemic, pre-meal chewable nutraceutical designed to help blunt post-meal blood sugar spikes is entering the UAE, Saudi Arabia and Kuwait. The region has roughly 7.5 million adults living with diabetes; the article provides no efficacy results or commercial projections.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
More News
- China’s Copper Squeeze Deepens as Buyers Scramble for Spot Metal
- Brazil’s central bank ends run of rate cuts after Lula election win
- Nifty Bounces Back to Beat All of Asia on Foreign Flows, Earnings
- Syria, Saudi Arabia sign defence cooperation deal, agree $403m in loans
- SpaceX signs deal with Qualcomm to provide network technology for U.S. mobile service
- How Abdul El-Sayed would build Medicare for All, from a wealth tax to a Fed-style governing board